Supplemental Grants

Supplemental Grants2021-04-07T16:47:34+00:00

*NEW* Regenerative Rehabilitation Supplemental Grants
Request for Applications

The AR3T Supplemental Grant Funding Program supports researchers in the development of innovative and rigorous, interdisciplinary Regenerative Rehabilitation research projects. AR3T is now soliciting supplemental grant proposals.

The Regenerative Rehabilitation research community will benefit from the development of novel lines of research that incorporate methods utilizing stimulation of stem cells and/or tissue engineering approaches and assessing stem cell behavior and/or functional outcomes.

The goal is to fund currently funded researchers who:

  • Would benefit from adding a component to enhance the rigor of  a Regenerative Rehabilitation research project
  • Could develop a line of innovative Regenerative Rehabilitation research by adding a regenerative medicine component to a funded rehabilitation research study or a regenerative medicine component to a funded rehabilitation research study.

We encourage you to consider consulting or collaborating with one of AR3T’s researchers. Contact if you have any questions.

Eligible Individuals: The AR3T supplemental funding program is open to junior – and mid-level career faculty. The Principal Investigator (PI) should have a doctoral degree in a relevant field and be employed at an institution within the United States. The goal is to fund researchers who are interested in beginning a career in Regenerative Rehabilitation research or who would like to start a new line of research in this area.


  • Up to $70,000 in funding will be awarded
  • Total award includes indirect costs by the awardee’s institution
Key Dates
RFA Release Date: April 1, 2021
Application Due Date: June 13, 2021
Notification Award Date: June 30, 2021
Anticipated Award Date: August 1, 2021

Additional Information

Review the application process and review criteria for more information.

For questions and/or assistance with proposal development, contact us at